FIIs have a look-in, may refrain from pharma, IT: IIFL
On how US President Donald Trump's protectionist policies may affect the IT and pharma stocks, Rahul Ajmera, CEO, US Office, IIFL Institutional Equities, said Trump has been in office for merely four weeks and it is too early to speculate.